{"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"groups":[{"description":"Autologous stem cell transplant: Autologous stem cell transplant following high-dose chemotherapy\n\nHigh-dose chemotherapy: High-dose chemotherapy with rituximab, thiotepa, busulfan, and cyclosphosphamide","id":"BG000","title":"High-dose Chemotherapy With Autologous Stem Cell Transplant"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"24","upperLimit":"74","value":"59"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"17"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"denoms":[{"counts":[{"groupId":"BG000","value":"0"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Race and Ethnicity were not collected from any participant.","title":"Race and Ethnicity Not Collected","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"30"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"27"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"title":"Diffuse Large B-cell Lymphoma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"title":"CLL/ SLL"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"title":"Follicular Non-Hodgkin lymphoma"}],"description":"CLL: Chronic lymphocytic leukemia SLL: Small lymphocytic lymphoma","paramType":"COUNT_OF_PARTICIPANTS","title":"Histology","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"29"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"title":"High-Dose Intravenous Methotrexate"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"title":"High-Dose Cytarabine"},{"categories":[{"measurements":[{"groupId":"BG000","value":"30"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"title":"Rituximab (Intravenous)"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"title":"Whole brain radiation therapy (WBRT)"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"title":"Other Radiation Therapy"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Prior Treatment History","unitOfMeasure":"Participants"}]}